Your browser doesn't support javascript.
loading
Risk of coronavirus disease 2019 hospitalization and mortality in rheumatic patients treated with hydroxychloroquine or other conventional disease-modifying anti-rheumatic drugs in Italy.
Spila Alegiani, Stefania; Crisafulli, Salvatore; Giorgi Rossi, Paolo; Mancuso, Pamela; Salvarani, Carlo; Atzeni, Fabiola; Gini, Rosa; Kirchmayer, Ursula; Belleudi, Valeria; Kurotschka, Peter Konstantin; Leoni, Olivia; Ludergnani, Monica; Ferroni, Eliana; Baracco, Susanna; Massari, Marco; Trifirò, Gianluca.
Afiliación
  • Spila Alegiani S; Pharmacoepidemiology Unit, National Centre for Drug Research and Evaluation, Istituto Superiore di Sanità, Rome, Italy.
  • Crisafulli S; Department of Biomedical and Dental Sciences and Morphofunctional Imaging, University of Messina, Messina, Italy.
  • Giorgi Rossi P; Italian Society of Pharmacology, Milan, Italy.
  • Mancuso P; Epidemiology Unit, Azienda Unità Sanitaria Locale-IRCCS di Reggio Emilia, Reggio Emilia, Italy.
  • Salvarani C; Epidemiology Unit, Azienda Unità Sanitaria Locale-IRCCS di Reggio Emilia, Reggio Emilia, Italy.
  • Atzeni F; Unit of Rheumatology, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy.
  • Gini R; Department of Surgery, Medicine, Dentistry and Morphological Sciences with Interest in Transplant, Oncology and Regenerative Medicine, University of Modena and Reggio Emilia, Modena, Emilia-Romagna, Italy.
  • Kirchmayer U; Rheumatology Unit, Department of Experimental and Internal Medicine, University of Messina, Messina, Italy.
  • Belleudi V; Agenzia Regionale di Sanità della Toscana, Florence, Italy.
  • Kurotschka PK; Department of Epidemiology ASL Roma 1, Lazio Regional Health Service, Rome, Italy.
  • Leoni O; Department of Epidemiology ASL Roma 1, Lazio Regional Health Service, Rome, Italy.
  • Ludergnani M; Department of Medical Sciences and Public Health, Faculty of Medicine and Surgery, University of Cagliari, Cagliari, Italy.
  • Ferroni E; Regional Health Trust of Sardinia Region, Cagliari, Italy.
  • Baracco S; Epidemiology Observatory-Department of Health of Lombardy Region, Milan, Italy.
  • Massari M; Epidemiology Observatory-Department of Health of Lombardy Region, Milan, Italy.
  • Trifirò G; Azienda Zero of the Veneto Region, Padua, Italy.
Rheumatology (Oxford) ; 60(SI): SI25-SI36, 2021 10 09.
Article en En | MEDLINE | ID: mdl-33856453

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedades Reumáticas / Antirreumáticos / Tratamiento Farmacológico de COVID-19 / Hospitalización / Hidroxicloroquina Tipo de estudio: Etiology_studies / Observational_studies / Risk_factors_studies / Screening_studies Límite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: Rheumatology (Oxford) Asunto de la revista: REUMATOLOGIA Año: 2021 Tipo del documento: Article País de afiliación: Italia

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedades Reumáticas / Antirreumáticos / Tratamiento Farmacológico de COVID-19 / Hospitalización / Hidroxicloroquina Tipo de estudio: Etiology_studies / Observational_studies / Risk_factors_studies / Screening_studies Límite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: Rheumatology (Oxford) Asunto de la revista: REUMATOLOGIA Año: 2021 Tipo del documento: Article País de afiliación: Italia